派姆单抗成功治疗源自假定卵巢成熟囊性畸胎瘤的鳞状细胞癌。
Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab.
作者信息
Wu Meng, Bennett Jennifer A, Reid Pankti, Fleming Gini F, Kurnit Katherine C
机构信息
Department of Medicine, University of Chicago, Chicago, IL, United States.
Department of Pathology, University of Chicago, Chicago, IL, United States.
出版信息
Gynecol Oncol Rep. 2021 Jul 22;37:100837. doi: 10.1016/j.gore.2021.100837. eCollection 2021 Aug.
Abstract
•Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown.•Pembrolizumab successfully treated a patient with metastatic SCC.•Patients on pembrolizumab should be monitored for immune-related adverse events.
摘要
•卵巢转移性鳞状细胞癌很少见，最佳治疗方法尚不清楚。
•帕博利珠单抗成功治疗了一名转移性鳞状细胞癌患者。
•使用帕博利珠单抗的患者应监测免疫相关不良事件。
Zotero 插件